1 Market Overview
1.1 Opioid-Induced Constipation Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Parenteral
1.3 Market Analysis by Application
1.3.1 Drugstore
1.3.2 Hospital
1.3.3 Others
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2015-2028)
1.4.2 Europe Market States and Outlook (2015-2028)
1.4.3 China Market States and Outlook (2015-2028)
1.4.4 Japan Market States and Outlook (2015-2028)
1.4.5 Southeast Asia Market States and Outlook (2015-2028)
1.4.6 India Market States and Outlook (2015-2028)
1.4.7 Brazil Market States and Outlook (2015-2028)
1.4.8 GCC Countries Market States and Outlook (2015-2028)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global Opioid-Induced Constipation Market Size Analysis from 2015 to 2028
1.6.1 Global Opioid-Induced Constipation Market Size Analysis from 2015 to 2028 by Consumption Volume
1.6.2 Global Opioid-Induced Constipation Market Size Analysis from 2015 to 2028 by Value
1.6.3 Global Opioid-Induced Constipation Price Trends Analysis from 2015 to 2028
2 Global Opioid-Induced Constipation Competition by Types, Applications, and Top Regions and Countries
2.1 Global Opioid-Induced Constipation (Volume and Value) by Type
2.1.1 Global Opioid-Induced Constipation Consumption and Market Share by Type (2015-2020)
2.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Type (2015-2020)
2.2 Global Opioid-Induced Constipation (Volume and Value) by Application
2.2.1 Global Opioid-Induced Constipation Consumption and Market Share by Application (2015-2020)
2.2.2 Global Opioid-Induced Constipation Revenue and Market Share by Application (2015-2020)
2.3 Global Opioid-Induced Constipation (Volume and Value) by Region
2.3.1 Global Opioid-Induced Constipation Consumption and Market Share by Region (2015-2020)
2.3.2 Global Opioid-Induced Constipation Revenue and Market Share by Region (2015-2020)
3 United States Opioid-Induced Constipation Market Analysis
3.1 United States Opioid-Induced Constipation Consumption and Value Analysis
3.2 United States Opioid-Induced Constipation Consumption Volume by Type
3.3 United States Opioid-Induced Constipation Consumption Structure by Application
4 Europe Opioid-Induced Constipation Market Analysis
4.1 Europe Opioid-Induced Constipation Consumption and Value Analysis
4.2 Europe Opioid-Induced Constipation Consumption Volume by Type
4.3 Europe Opioid-Induced Constipation Consumption Structure by Application
4.4 Europe Opioid-Induced Constipation Consumption by Top Countries
4.4.1 Germany Opioid-Induced Constipation Consumption Volume from 2015 to 2020
4.4.2 UK Opioid-Induced Constipation Consumption Volume from 2015 to 2020
4.4.3 France Opioid-Induced Constipation Consumption Volume from 2015 to 2020
4.4.4 Italy Opioid-Induced Constipation Consumption Volume from 2015 to 2020
4.4.5 Spain Opioid-Induced Constipation Consumption Volume from 2015 to 2020
4.4.6 Poland Opioid-Induced Constipation Consumption Volume from 2015 to 2020
4.4.7 Russia Opioid-Induced Constipation Consumption Volume from 2015 to 2020
5 China Opioid-Induced Constipation Market Analysis
5.1 China Opioid-Induced Constipation Consumption and Value Analysis
5.2 China Opioid-Induced Constipation Consumption Volume by Type
5.3 China Opioid-Induced Constipation Consumption Structure by Application
6 Japan Opioid-Induced Constipation Market Analysis
6.1 Japan Opioid-Induced Constipation Consumption and Value Analysis
6.2 Japan Opioid-Induced Constipation Consumption Volume by Type
6.3 Japan Opioid-Induced Constipation Consumption Structure by Application
7 Southeast Asia Opioid-Induced Constipation Market Analysis
7.1 Southeast Asia Opioid-Induced Constipation Consumption and Value Analysis
7.2 Southeast Asia Opioid-Induced Constipation Consumption Volume by Type
7.3 Southeast Asia Opioid-Induced Constipation Consumption Structure by Application
7.4 Southeast Asia Opioid-Induced Constipation Consumption by Top Countries
7.4.1 Indonesia Opioid-Induced Constipation Consumption Volume from 2015 to 2020
7.4.2 Thailand Opioid-Induced Constipation Consumption Volume from 2015 to 2020
7.4.3 Philippines Opioid-Induced Constipation Consumption Volume from 2015 to 2020
7.4.4 Malaysia Opioid-Induced Constipation Consumption Volume from 2015 to 2020
7.4.5 Singapore Opioid-Induced Constipation Consumption Volume from 2015 to 2020
7.4.6 Vietnam Opioid-Induced Constipation Consumption Volume from 2015 to 2020
8 India Opioid-Induced Constipation Market Analysis
8.1 India Opioid-Induced Constipation Consumption and Value Analysis
8.2 India Opioid-Induced Constipation Consumption Volume by Type
8.3 India Opioid-Induced Constipation Consumption Structure by Application
9 Brazil Opioid-Induced Constipation Market Analysis
9.1 Brazil Opioid-Induced Constipation Consumption and Value Analysis
9.2 Brazil Opioid-Induced Constipation Consumption Volume by Type
9.3 Brazil Opioid-Induced Constipation Consumption Structure by Application
10 GCC Countries Opioid-Induced Constipation Market Analysis
10.1 GCC Countries Opioid-Induced Constipation Consumption and Value Analysis
10.2 GCC Countries Opioid-Induced Constipation Consumption Volume by Type
10.3 GCC Countries Opioid-Induced Constipation Consumption Structure by Application
10.4 GCC Countries Opioid-Induced Constipation Consumption Volume by Major Countries
10.4.1 Saudi Arabia Opioid-Induced Constipation Consumption Volume from 2015 to 2020
10.4.2 United Arab Emirates Opioid-Induced Constipation Consumption Volume from 2015 to 2020
10.4.3 Qatar Opioid-Induced Constipation Consumption Volume from 2015 to 2020
10.4.4 Bahrain Opioid-Induced Constipation Consumption Volume from 2015 to 2020
11 Manufacturers Profiles
11.1 Boehringer Ingelheim
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 Boehringer Ingelheim Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.1.4 Boehringer Ingelheim Opioid-Induced Constipation Sales by Region
11.2 Shionogi
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 Shionogi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.2.4 Shionogi Opioid-Induced Constipation Sales by Region
11.3 Mundipharma
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 Mundipharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.3.4 Mundipharma Opioid-Induced Constipation Sales by Region
11.4 Valeant Pharmaceuticals International
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 Valeant Pharmaceuticals International Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.4.4 Valeant Pharmaceuticals International Opioid-Induced Constipation Sales by Region
11.5 Daewoong
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 Daewoong Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.5.4 Daewoong Opioid-Induced Constipation Sales by Region
11.6 Progenics Pharmaceuticals
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.6.4 Progenics Pharmaceuticals Opioid-Induced Constipation Sales by Region
11.7 Cosmo Pharmaceuticals
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 Cosmo Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.7.4 Cosmo Pharmaceuticals Opioid-Induced Constipation Sales by Region
11.8 Takeda Pharmaceutical
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 Takeda Pharmaceutical Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.8.4 Takeda Pharmaceutical Opioid-Induced Constipation Sales by Region
11.9 Theravance
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 Theravance Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.9.4 Theravance Opioid-Induced Constipation Sales by Region
11.10 Synergy Pharmaceuticals
11.10.1 Business Overview
11.10.2 Products Analysis
11.10.3 Synergy Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.10.4 Synergy Pharmaceuticals Opioid-Induced Constipation Sales by Region
11.11 Ironwood Pharmaceuticals
11.11.1 Business Overview
11.11.2 Products Analysis
11.11.3 Ironwood Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.11.4 Ironwood Pharmaceuticals Opioid-Induced Constipation Sales by Region
11.12 Pfizer
11.12.1 Business Overview
11.12.2 Products Analysis
11.12.3 Pfizer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.12.4 Pfizer Opioid-Induced Constipation Sales by Region
11.13 Daiichi Sankyo
11.13.1 Business Overview
11.13.2 Products Analysis
11.13.3 Daiichi Sankyo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.13.4 Daiichi Sankyo Opioid-Induced Constipation Sales by Region
11.14 GlaxoSmithKline
11.14.1 Business Overview
11.14.2 Products Analysis
11.14.3 GlaxoSmithKline Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.14.4 GlaxoSmithKline Opioid-Induced Constipation Sales by Region
11.15 Merck
11.15.1 Business Overview
11.15.2 Products Analysis
11.15.3 Merck Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.15.4 Merck Opioid-Induced Constipation Sales by Region
11.16 AstraZeneca
11.16.1 Business Overview
11.16.2 Products Analysis
11.16.3 AstraZeneca Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.16.4 AstraZeneca Opioid-Induced Constipation Sales by Region
11.17 Abbott
11.17.1 Business Overview
11.17.2 Products Analysis
11.17.3 Abbott Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.17.4 Abbott Opioid-Induced Constipation Sales by Region
11.18 Nektar Therapeutics
11.18.1 Business Overview
11.18.2 Products Analysis
11.18.3 Nektar Therapeutics Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.18.4 Nektar Therapeutics Opioid-Induced Constipation Sales by Region
11.19 Johnson and Johnson
11.19.1 Business Overview
11.19.2 Products Analysis
11.19.3 Johnson and Johnson Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.19.4 Johnson and Johnson Opioid-Induced Constipation Sales by Region
11.20 Bayer
11.20.1 Business Overview
11.20.2 Products Analysis
11.20.3 Bayer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.20.4 Bayer Opioid-Induced Constipation Sales by Region
11.21 SLA Pharma
11.21.1 Business Overview
11.21.2 Products Analysis
11.21.3 SLA Pharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.21.4 SLA Pharma Opioid-Induced Constipation Sales by Region
11.22 C.B. Fleet
11.22.1 Business Overview
11.22.2 Products Analysis
11.22.3 C.B. Fleet Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.22.4 C.B. Fleet Opioid-Induced Constipation Sales by Region
11.23 Sucampo
11.23.1 Business Overview
11.23.2 Products Analysis
11.23.3 Sucampo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin
11.23.4 Sucampo Opioid-Induced Constipation Sales by Region
13 Global Opioid-Induced Constipation Market Forecast (2020-2028)
13.1 Global Opioid-Induced Constipation Consumption Volume, Revenue and Price Forecast (2020-2028)
13.1.1 Global Opioid-Induced Constipation Consumption Volume and Growth Rate Forecast (2020-2028)
13.1.2 Global Opioid-Induced Constipation Value and Growth Rate Forecast (2020-2028)
13.1.3 Global Opioid-Induced Constipation Price and Trend Forecast (2020-2028)
13.2 Global Opioid-Induced Constipation Consumption Volume, Value and Growth Rate Forecast by Region (2020-2028)
13.2.1 Global Opioid-Induced Constipation Consumption Volume and Growth Rate Forecast by Region (2020-2028)
13.2.2 Global Opioid-Induced Constipation Value and Growth Rate Forecast by Region (2020-2028)
13.3 Global Opioid-Induced Constipation Consumption Volume, Revenue and Price Forecast by Type (2020-2028)
13.3.1 Global Opioid-Induced Constipation Consumption Forecast by Type (2020-2028)
13.3.2 Global Opioid-Induced Constipation Revenue Forecast by Type (2020-2028)
13.3.3 Global Opioid-Induced Constipation Price Forecast by Type (2020-2028)
13.4 Global Opioid-Induced Constipation Consumption Volume Forecast by Application (2020-2028)
14 Research Conclusions
15 Appendix
15.1 Methodology
15.2 Research Data Source
